newsfilter
← Latest News
FDA Approved Drugs·

Approval of Afrezza, Bla #022472

Approval Date: 01/26/2026; Drug Name: Afrezza, Bla #022472; Active Ingredients: INSULIN RECOMBINANT HUMAN; Company: Mannkind; Submission Status: Approval; Application Number: 022472

Company
MANNKIND
Keywords
MANNKIND